Trends in the Diagnosis and Treatment of Patients with Medullary Thyroid Carcinoma in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, Hwa Young | - |
dc.contributor.author | Chae, Jae Eun | - |
dc.contributor.author | Moon, Hyemi | - |
dc.contributor.author | Noh, Junghyun | - |
dc.contributor.author | Park, Young Joo | - |
dc.contributor.author | Kim, Sin Gon | - |
dc.date.accessioned | 2021-08-30T06:40:22Z | - |
dc.date.available | 2021-08-30T06:40:22Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2020-12 | - |
dc.identifier.issn | 2093-596X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/51256 | - |
dc.description.abstract | Background: Thyroid cancer is becoming increasingly common worldwide, but little is known about the epidemiology of medullary thyroid carcinoma (MTC). This study investigated the current status of the incidence and treatment of MTC using Korean National Health Insurance Service (NHIS) data for the entire Korean population from 2004 to 2016. Methods: This study included 1,790 MTC patients identified from the NHIS database. Results: The age-standardized incidence rate showed a slightly decreasing or stationary trend during the period, from 0.25 per 100,000 persons in 2004 to 0.19 in 2016. The average proportion of MTC among all thyroid cancers was 0.5%. For initial surgical treatment, 65.4% of patients underwent total thyroidectomy. After surgery, external-beam radiation therapy (EBRT) was performed in 10% of patients, a proportion that increased from 6.7% in 2004 to 11.0% in 2016. Reoperations were performed in 2.7% of patients (n=49) at a median of 1.9 years of follow-up (interquartile range, 1.2 to 3.4). Since November 2015, 25 (1.4%) patients with MTC were prescribed vandetanib by December 2016. Conclusion: The incidence of MTC decreased slightly with time, and the proportion of patients who underwent total thyroidectomy was about 65%. EBRT, reoperation, and tyrosine kinase inhibitor therapy are additional treatments after initial surgery for advanced MTC in Korea. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ENDOCRINE SOC | - |
dc.subject | PROGNOSTIC-FACTORS | - |
dc.subject | CANCER INCIDENCE | - |
dc.subject | RADIOACTIVE IODINE | - |
dc.subject | SURVIVAL | - |
dc.subject | MORTALITY | - |
dc.subject | OUTCOMES | - |
dc.title | Trends in the Diagnosis and Treatment of Patients with Medullary Thyroid Carcinoma in Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Sin Gon | - |
dc.identifier.doi | 10.3803/EnM.2020.709 | - |
dc.identifier.scopusid | 2-s2.0-85099103624 | - |
dc.identifier.wosid | 000607096500013 | - |
dc.identifier.bibliographicCitation | ENDOCRINOLOGY AND METABOLISM, v.35, no.4, pp.811 - 819 | - |
dc.relation.isPartOf | ENDOCRINOLOGY AND METABOLISM | - |
dc.citation.title | ENDOCRINOLOGY AND METABOLISM | - |
dc.citation.volume | 35 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 811 | - |
dc.citation.endPage | 819 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002661665 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.subject.keywordPlus | PROGNOSTIC-FACTORS | - |
dc.subject.keywordPlus | CANCER INCIDENCE | - |
dc.subject.keywordPlus | RADIOACTIVE IODINE | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordAuthor | Epidemiology | - |
dc.subject.keywordAuthor | Incidence | - |
dc.subject.keywordAuthor | Thyroid cancer, medullary | - |
dc.subject.keywordAuthor | Therapeutics | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.